OMX Nordic 40
|
2 678,58
|
-6,98
|
-0,26 %
|
Analysen zu OMX Nordic 40-Werten
| 13.09.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 12.09.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.09.24 | Novo Nordisk Neutral | UBS AG | |
| 11.09.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 10.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.09.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
| 10.09.24 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Sell | UBS AG | |
| 09.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 06.09.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.09.24 | Volvo AB Buy | Jefferies & Company Inc. | |
| 03.09.24 | Volvo AB Sector Perform | RBC Capital Markets | |
| 03.09.24 | ABB Sector Perform | RBC Capital Markets | |
| 03.09.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |